Human Trials Begin on Antibody Treatment for COVID-19
A small trial of 32 patients is evaluating a new antibody drug developed specifically to fight the novel coronavirus. The trial will determine what, if any, side effects arise. Discovered by Vancouver-based AbCellera and developed by Eli…